Edwards Lifesciences Corp (EW)
Receivables turnover
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 5,883,800 | 5,685,100 | 5,538,800 | 5,456,000 | 5,336,600 | 5,225,600 | 5,135,200 | 5,264,900 | 5,346,800 | 5,422,400 | 5,500,800 | 5,382,400 | 5,363,800 | 5,355,000 | 5,357,100 | 5,232,500 | 5,094,500 | 4,925,200 | 4,474,200 | 4,386,300 |
| Receivables | US$ in thousands | 892,800 | 902,600 | 751,900 | 727,400 | 811,500 | 834,400 | 876,900 | 828,100 | 802,100 | 816,900 | 779,300 | 699,100 | 661,400 | 679,200 | 686,200 | 664,900 | 664,200 | 700,300 | 664,300 | 602,800 |
| Receivables turnover | 6.59 | 6.30 | 7.37 | 7.50 | 6.58 | 6.26 | 5.86 | 6.36 | 6.67 | 6.64 | 7.06 | 7.70 | 8.11 | 7.88 | 7.81 | 7.87 | 7.67 | 7.03 | 6.74 | 7.28 |
September 30, 2025 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $5,883,800K ÷ $892,800K
= 6.59
Peer comparison
Sep 30, 2025
Company name
Symbol
Receivables turnover
Edwards Lifesciences Corp
EW
6.59
Abbott Laboratories
ABT
4.22
Artivion Inc
AORT
4.26
Bio-Rad Laboratories Inc
BIO
5.61
Boston Scientific Corp
BSX
6.84
Bruker Corporation
BRKR
6.31
CONMED Corporation
CNMD
5.99
DexCom Inc
DXCM
3.83
GE HealthCare Technologies Inc.
GEHC
4.96
Inspire Medical Systems Inc
INSP
8.17
Quidel Corporation
QDEL
5.29
See also:
Edwards Lifesciences Corp Receivables Turnover (Quarterly Data)